10 Stocks With At Least $10 Million In Insider Spending Recently

8. Metsera, Inc. (NASDAQ:MTSR)

Highest Individual Purchase: $14,219,964.00

Number of Purchases Worth Between $10 million and $20 million: 3

Market Capitalization: $2.55 billion

The eighth stock on this list of 10 stocks with at least $10 million in insider spending recently is a clinical-stage biotechnology company. Metsera focuses on developing injectable and oral nutrient-stimulated hormone analog peptides to treat obesity and metabolic diseases. The New York City-based company is advancing its broad portfolio of therapies with the potential to address various therapeutic targets and meet the needs of the weight loss treatment industry. It was founded in 2022 by Population Health Partners and ARCH Venture Partners.

On February 3rd, three insiders acquired a total of $94.22 million in Metsera shares at $18 per share during the company’s initial public offering. The company raised $257 million during its IPO, pricing shares above its targeted range. Of the five purchases, three were valued at $14.22 million each. The stock is currently trading at $24.78.

In January, the company shared promising results from a 12-week Phase 2a clinical trial of its leading candidate, MET-097i, a potential once-monthly injectable treatment for obesity. The data showed that MET-097i helped participants achieve significant weight loss, with some losing up to 20% of their body weight, and it was generally well tolerated, with only mild side effects. The company is planning additional studies in 2025.

According to data from StockAnalysis, four analysts have given Metsera stock an average ‘Strong Buy’ rating, with a price target of $47.

Metsera is also one of 10 stocks insiders spent the most money on recently.